RCM Technologies Q3 EPS Rises to $0.37; Material Weaknesses Persist
RCMT sits 91% above its 52-week low of $17.26 on light trading volume (0.3× avg).
Summary
RCM Technologies reported Q3 FY2026 revenue of $73.4 million and diluted EPS of $0.37, up from $0.30 a year ago, while disclosing that its previously identified material weaknesses in internal controls remained unremediated as of October 3, 2026.
Key Events · Earnings and Guidance · RCMT
-
Q3 Revenue and Earnings Grow
Revenue rose to $73.4 million from $70.3 million and net income to $2.7 million from $2.3 million; diluted EPS was $0.37 versus $0.30.
-
Specialty Health Care Margin Compresses
Segment gross margin fell to 25.5% from 30.0% on a mix shift toward lower-margin services and slower-than-typical summer school assignments, pulling segment operating income to $2.3 million from $2.7 million.
-
Material Weaknesses Remain Unremediated
Management concluded disclosure controls and procedures were not effective as of October 3, 2026 because the material weaknesses identified at January 3, 2026 continued to exist; remediation is in progress with timing uncertain.
-
Liquidity Tighter on Working Capital
Cash fell to $1.9 million from $2.9 million, with $22.7 million drawn on the revolver and $23.5 million of remaining availability; nine-month operating cash flow was $9.8 million.
Analysis · RCMT · Trade & Services
RCM grew third-quarter revenue 4.4% to $73.4 million and lifted net income to $2.7 million ($0.37 diluted) from $2.3 million a year ago, but the quality of the beat is mixed: Specialty Health Care gross margin compressed to 25.5% from 30.0% on a mix shift toward lower-margin work and slower summer school assignments, and the Engineering segment's revenue slipped 2.2%. The bigger overhang is governance — management again concluded disclosure controls were not effective as of October 3, 2026 because the previously disclosed material weaknesses in internal control over financial reporting remain unremediated, with completion timing uncertain. That keeps a control-risk discount on the stock even as earnings improve, and it sits alongside heavy insider distribution over the past 90 days.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RCMT was trading at $32.96 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $247.6M. The 52-week trading range was $17.26 to $43.68. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.